EE200200189A - Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt - Google Patents

Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Info

Publication number
EE200200189A
EE200200189A EEP200200189A EEP200200189A EE200200189A EE 200200189 A EE200200189 A EE 200200189A EE P200200189 A EEP200200189 A EE P200200189A EE P200200189 A EEP200200189 A EE P200200189A EE 200200189 A EE200200189 A EE 200200189A
Authority
EE
Estonia
Prior art keywords
leptin
vector
substance
determination
assay kit
Prior art date
Application number
EEP200200189A
Other languages
English (en)
Estonian (et)
Inventor
Rubinstein Menachem
Cohen Batya
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200200189A publication Critical patent/EE200200189A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
EEP200200189A 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt EE200200189A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13231399A IL132313A0 (en) 1999-10-11 1999-10-11 Leptin assay
PCT/IL2000/000621 WO2001027319A2 (en) 1999-10-10 2000-10-05 Leptin assay based on detecting ang-2 expression

Publications (1)

Publication Number Publication Date
EE200200189A true EE200200189A (et) 2003-06-16

Family

ID=11073317

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200189A EE200200189A (et) 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Country Status (24)

Country Link
US (1) US7247427B1 (pt)
EP (1) EP1222467B1 (pt)
JP (1) JP2003511057A (pt)
KR (1) KR100863580B1 (pt)
CN (1) CN1159585C (pt)
AR (1) AR025995A1 (pt)
AT (1) ATE322017T1 (pt)
AU (1) AU778727B2 (pt)
BR (1) BR0014626A (pt)
CA (1) CA2386365A1 (pt)
CY (1) CY1105025T1 (pt)
DE (1) DE60027031T2 (pt)
DK (1) DK1222467T3 (pt)
EA (1) EA004709B1 (pt)
EE (1) EE200200189A (pt)
ES (1) ES2256045T3 (pt)
HK (1) HK1048514B (pt)
IL (2) IL132313A0 (pt)
NO (1) NO20021604L (pt)
PT (1) PT1222467E (pt)
SI (1) SI1222467T1 (pt)
UA (1) UA77153C2 (pt)
WO (1) WO2001027319A2 (pt)
ZA (1) ZA200202155B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2372364A1 (en) * 2010-03-31 2011-10-05 Medizinische Hochschule Hannover Biomarker for pulmonary hypertension
EP2661266B1 (en) 2011-01-07 2020-09-16 Anji Pharma (US) LLC Chemosensory receptor ligand-based therapies
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
CN102221615A (zh) * 2011-03-31 2011-10-19 广州华灿医药科技有限公司 一种基于Angiogenin检测的双抗夹心ELISA方法
KR20190120430A (ko) 2012-01-06 2019-10-23 엘셀릭스 테라퓨틱스 인코포레이티드 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
EP2800562A2 (en) 2012-01-06 2014-11-12 Elcelyx Therapeutics, Inc. Compositions and methods for treating metabolic disorders
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
HK1210825A1 (en) 2012-07-11 2016-05-06 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN102901823A (zh) * 2012-10-26 2013-01-30 安徽安科生物工程（集团）股份有限公司 瘦素检测试剂盒
CN105101956B (zh) 2013-01-05 2018-12-07 埃尔舍利克斯治疗公司 包含双胍的延迟释放组合物
CN104459105B (zh) * 2014-12-05 2016-03-09 重庆中元生物技术有限公司 一种检测lp的胶乳增强免疫比浊试剂盒及其制备方法
CN115901697B (zh) * 2021-08-26 2026-03-17 苏州生物医药转化工程中心 一种检测瘦素相关蛋白或其类似物的活性的方法
CN114940717B (zh) * 2022-06-30 2024-04-26 武汉海特生物制药股份有限公司 嵌合受体、32d瘦素敏感细胞株及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914611A4 (en) 1996-04-22 2002-10-16 Merck & Co Inc TRANSACTIVATION OF LEPTIN

Also Published As

Publication number Publication date
IL132313A0 (en) 2001-03-19
IL149021A0 (en) 2002-11-10
SI1222467T1 (sl) 2006-06-30
KR100863580B1 (ko) 2008-10-15
CA2386365A1 (en) 2001-04-19
JP2003511057A (ja) 2003-03-25
US7247427B1 (en) 2007-07-24
PT1222467E (pt) 2006-06-30
UA77153C2 (en) 2006-11-15
AU7814100A (en) 2001-04-23
NO20021604D0 (no) 2002-04-04
AR025995A1 (es) 2002-12-26
ES2256045T3 (es) 2006-07-16
WO2001027319A2 (en) 2001-04-19
DE60027031T2 (de) 2006-08-24
CN1378648A (zh) 2002-11-06
HK1048514A1 (en) 2003-04-04
AU778727B2 (en) 2004-12-16
DK1222467T3 (da) 2006-08-07
EA004709B1 (ru) 2004-06-24
HK1048514B (zh) 2004-12-31
CN1159585C (zh) 2004-07-28
DE60027031D1 (de) 2006-05-18
WO2001027319A3 (en) 2001-06-21
CY1105025T1 (el) 2010-03-03
IL149021A (en) 2007-12-03
ZA200202155B (en) 2003-05-28
EP1222467A2 (en) 2002-07-17
ATE322017T1 (de) 2006-04-15
EP1222467B1 (en) 2006-03-29
NO20021604L (no) 2002-04-04
BR0014626A (pt) 2002-06-11
EA200200435A1 (ru) 2002-10-31
KR20020048416A (ko) 2002-06-22

Similar Documents

Publication Publication Date Title
ID25764A (id) Turunan-turunan ftalamida, atau garam-garamnya untuk insektisida agroholtikultura, dan metode penggunaannya
DE60130043D1 (de) Grundierungszusammensetzung und Beschichtungsverfahren
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
DE60132732D1 (de) Primerzusammensetzung und Verbindungsverfahren
DE60103218D1 (de) Zugagangspunkt und Verfahren zur Verbindungssteuerung
DE60010923D1 (de) Vernetzbare kautschukzusammensetzung und vernetzter gegenstand
NL1014545A1 (nl) Oxim-derivaten en de toepassing daarvan als latente zuren.
AU2001252973A1 (en) Biosensor and related method
HUP0300371A3 (en) Tag library compounds, compositions, kits and methods of use
ID29335A (id) Aparatus dan metode pengontrolan
DE69928874D1 (de) Tonerzusammensetzung, Entwickler und Herstellungsverfahren
MXPA03007827A (es) Metodo y composicion para la coloracion permanente gradual de cabello.
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2002243391A1 (en) Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
ID22956A (id) Sintesa disulfida dan polisulfida organik
EE200200189A (et) Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt
AU2001274817A1 (en) Agents that modulate dna-pk activity and methods of use thereof
AU2001274560A1 (en) Substrate activation kit and method of detecting dna or the like by using the same
FI20001381L (fi) Menetelmä häiriön vaikutuksen minimoimiseksi ja vastaanotin
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
AU5122500A (en) Detection of biological warfare agents
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AU2001256892A1 (en) Reagent for detection of biomolecules, and use thereof
AU2001288357A1 (en) Methods of preventing or treating west nile virus and other infections
BR0110603B1 (pt) couro natural revestido com poliuretano e mÉtodo de preparaÇço de couro natural revestido.